March 30, 2023
You are here:  Home  >  Features  >  Current Article

Better than a biopsy: Cynvenio technology could diagnose cancer from blood


André de Fusco, CEO of Cynvenio Biosystem’s with one of the firm’s machines. The company’s new technology promises to diagnose cancer from blood samples rather than biopsies. (Stephen Nellis photo) Cynvenio Biosystems has developed a new technology that could revolutionize the way cancer is diagnosed and treated. With the help of new blood-screening technology developed…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.